Using chlorhexidine dressings to prevent infections in pediatric cancer patients with catheters
Official title: Care Bundle Containing Chlorhexidine Dressing on Port Catheter and Central Venous Catheter-Related Bloodstream Infections in Pediatric Cancer Patients
Run by Dokuz Eylul University · NCT06720064 · Data updated 2026-11-12
This study is testing if using special dressings with chlorhexidine can help prevent infections in young cancer patients who have catheters.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 1 Year to 17 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Dokuz Eylul University Academic / other |
| Locations | 1 site (Izmir) |
| Status | Recruiting |
| Started | May 7, 2024 |
| Main results expected | December 2025 |
| Study ends | December 2025 |
| Registry record updated | December 6, 2024 |
| Trial ID | NCT06720064 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 1 to 17 who are receiving inpatient treatment for hematological or oncological cancers and have a port catheter inserted.
✕Probably not a fit
Patients with existing systemic infections will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study examines the effectiveness of a care bundle that includes chlorhexidine dressings in reducing catheter-related bloodstream infections in pediatric patients with cancer. It is a prospective, cross-sectional, and randomized controlled study that involves stratified randomization based on various factors such as age and type of cancer. The goal is to determine if this approach can lower the incidence of infections and complications associated with port and central venous catheters in this vulnerable population.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the risk of serious infections in pediatric cancer patients requiring catheterization.
How similar studies have gone: Other studies have shown promising results with similar care bundle approaches in reducing catheter-related infections, suggesting potential for success in this study.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The child is receiving inpatient treatment at the Hematology and Oncology unit and hematopoietic stem cell transplantation unit * The child has a diagnosis of hematological or oncological cancer * The child's age range is between 1 and 17 * Having a port catheter inserted and no early complications have occurred * The child agrees to participate in the study voluntarily * The parent agrees to participate in the study voluntarily * Obtaining the consent form from the child and parent * He has been in the hospital for more than 48 hours Exclusion Criteria: * Have a systemic infection.
Where it's running
-
Gülçin Özalp Gerçeker
Izmir, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Gulcin Ozalp Gerceker, Assoc. Prof. — Dokuz Eylul University
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FaceSay: a computer program to help kids recognize facial expressions and improve social interactions
A computer-based FaceSay program is tested to see if it helps survivors of pediatric brain tumors who have social difficulties see facial expressions better and relate more comfortably with peers.
-
Access to Innovative Cancer Treatments for Children and Young People in Belgium
This observational study collects safety and effectiveness data on off‑label and compassionate cancer medicines used in kids and young adults up to age 25 in Belgium.
-
BCB-276 CAR T therapy for DIPG in children and young adults
This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.
-
CAYA cancer patients in LMICs: a forward-looking observation of care and outcomes
This study follows children, teens, and young adults with cancer in low- and middle-income countries to see how routine care affects treatment, access, and outcomes over time.
-
Virtual reality headsets to reduce anxiety and fear during intrathecal chemotherapy in children
This project will try virtual reality headsets with children aged 4–10 who are receiving intrathecal chemotherapy to see if they reduce anxiety, fear, and changes in vital signs.
-
Laser thermal therapy for young people with low-grade glioma
This research will test whether laser interstitial thermal therapy (LITT) can stop or slow recurrent or progressive low-grade gliomas in children, adolescents, and young adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.